Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond A Lorenz

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|August 28, 2010
Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorderRaymond A Lorenz, Cherry W Jackson, Marianne Saitz
International Journal of Psychiatry in Medicine|July 16, 2008
Serotonergic antidepressants and linezolid: a retrospective chart review and presentation of casesRaymond A Lorenz, Amy M Vandenberg, Elizabeth A Canepa
Pharmacogenomics and Personalized Medicine|August 31, 2016
Use of combinatorial pharmacogenomic testing in two cases from community psychiatryEve S Fields, Raymond A Lorenz, Joel G Winner
Clinical Therapeutics|February 28, 2017
Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care SettingLisa C Brown, Raymond A Lorenz, James Li, et al.
International Journal of Psychiatry in Medicine|February 20, 2014
Factors associated with influenza vaccination decisions among patients with mental illnessRaymond A Lorenz, Meghan M Norris, Leah C Norton, et al.
The Primary Care Companion for CNS Disorders|September 4, 2012
Prazosin for the treatment of nightmares related to posttraumatic stress disorder: a review of the literatureSteven M Hudson, Travis E Whiteside, Raymond A Lorenz, et al.
Journal of Neuroimmunology|May 1, 2022
Changes in ganglioside antibody positivity rates during the COVID-19 pandemicMichael K Racke, Justin K Niles, Raymond A Lorenz, et al.
Population Health Management|October 27, 2022
Role of Pharmacogenomics in Comprehensive Medication Management: Considerations for EmployersMaren S Fragala, Jeffrey A Shaman, Raymond A Lorenz, et al.
The Pharmacogenomics Journal|October 2, 2024
Clinical and economic outcomes of a pharmacogenomics-enriched comprehensive medication management program in a self-insured employee populationMaren S Fragala, Murray Keogh, Steven E Goldberg, et al.
Journal of Occupational and Environmental Medicine|September 26, 2022
Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee PopulationMurray Keogh, Maren S Fragala, Arul Prakasam Peter, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|August 28, 2010
Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorderRaymond A Lorenz, Cherry W Jackson, Marianne Saitz
International Journal of Psychiatry in Medicine|July 16, 2008
Serotonergic antidepressants and linezolid: a retrospective chart review and presentation of casesRaymond A Lorenz, Amy M Vandenberg, Elizabeth A Canepa
Pharmacogenomics and Personalized Medicine|August 31, 2016
Use of combinatorial pharmacogenomic testing in two cases from community psychiatryEve S Fields, Raymond A Lorenz, Joel G Winner
Clinical Therapeutics|February 28, 2017
Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care SettingLisa C Brown, Raymond A Lorenz, James Li, et al.
International Journal of Psychiatry in Medicine|February 20, 2014
Factors associated with influenza vaccination decisions among patients with mental illnessRaymond A Lorenz, Meghan M Norris, Leah C Norton, et al.
The Primary Care Companion for CNS Disorders|September 4, 2012
Prazosin for the treatment of nightmares related to posttraumatic stress disorder: a review of the literatureSteven M Hudson, Travis E Whiteside, Raymond A Lorenz, et al.
Journal of Neuroimmunology|May 1, 2022
Changes in ganglioside antibody positivity rates during the COVID-19 pandemicMichael K Racke, Justin K Niles, Raymond A Lorenz, et al.
Population Health Management|October 27, 2022
Role of Pharmacogenomics in Comprehensive Medication Management: Considerations for EmployersMaren S Fragala, Jeffrey A Shaman, Raymond A Lorenz, et al.
The Pharmacogenomics Journal|October 2, 2024
Clinical and economic outcomes of a pharmacogenomics-enriched comprehensive medication management program in a self-insured employee populationMaren S Fragala, Murray Keogh, Steven E Goldberg, et al.
Journal of Occupational and Environmental Medicine|September 26, 2022
Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee PopulationMurray Keogh, Maren S Fragala, Arul Prakasam Peter, et al.
Pageof 2